Nucleic Acid Amplification Testing Market Outlook Assessing Future Opportunities And Growth Prospects
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Nucleic Acid Amplification Testing Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The nucleic acid amplification testing market size has shown swift expansion in recent years. It is anticipated to expand from $11.03 billion in 2025 to $12.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.2%. During the historical period, this growth can be attributed to elements such as infectious disease outbreaks, the increase in clinical laboratories, the adoption of PCR technology, public health screening programs, and a reduction in assay costs.
The nucleic acid amplification testing market size is projected to experience swift expansion in the coming years. It is anticipated to reach $22.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.8%. Factors contributing to this growth during the forecast period include the rise of personalized medicine, increasing demand for prompt diagnostics, market expansion in developing regions, advancements in technological miniaturization, and regulatory endorsements for innovative assays. Key trends expected throughout this period encompass expedited point-of-care molecular testing, the broadening of multiplex and syndromic panels, the escalating uptake of isothermal amplification methods, the proliferation of home-based and decentralized testing solutions, and a heightened emphasis on the early detection of diseases.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp
Which Significant Factors Are Encouraging Growth In The Nucleic Acid Amplification Testing Market?
The nucleic acid amplification testing market is projected to expand due to the rising occurrence of infectious diseases. These conditions originate from organisms capable of direct or indirect human transmission through diverse pathways like physical interaction, airborne particles, tainted food or water, or insect vectors. Factors contributing to the increase in infectious diseases include antibiotic resistance, shifts in climate, alterations in human conduct, and agricultural methods. Nucleic acid amplification testing (NAAT) provides quick and precise identification of infectious pathogens, enabling prompt diagnosis and treatment, which in turn aids in managing disease dissemination. For instance, data from the Public Health Agency of Canada, a governmental body in Canada, indicated 4,216 influenza-related hospitalizations across participating provinces and territories during the 2022–2023 season, as noted in October 2023. Consequently, the growing frequency of infectious diseases is a key driver for the expansion of the nucleic acid amplification testing market.
How Is The Nucleic Acid Amplification Testing Market Distributed Across Key Segments?
The nucleic acid amplification testing market covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Amplification Method: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
Which Trends Are Guiding The Development Of The Nucleic Acid Amplification Testing Market?
Major companies engaged in the nucleic acid amplification testing market are prioritizing the development of innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for CMV using nucleic acid amplification technology (NAT) under the IVDR. An IVD (in vitro diagnostic) assay is a test performed on biological samples to identify diseases, conditions, or infections outside the body in a laboratory setting. For instance, in June 2024, GFE, a Germany-based company, introduced the PoET CMV. The PoET CMV, an IVD assay, is specifically engineered for the rapid and precise detection of cytomegalovirus (CMV) infections. Its distinct features include high sensitivity and specificity, which enable early diagnosis and effective monitoring of CMV in transplant patients and immunocompromised individuals. This assay employs advanced molecular techniques to deliver reliable results quickly, thereby supporting timely clinical decision-making.
Who Are The Key Market Participants In The Nucleic Acid Amplification Testing Market?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
Access The Complete Nucleic Acid Amplification Testing Market Report:
Which Area Represents The Largest Portion Of The Nucleic Acid Amplification Testing Market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Nucleic Acid Amplification Testing Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Nucleic Acid Amplification Testing Market 2026, By The Business Research Company
Nucleic Acid Based Gene Therapy Market Report 2026
Nucleic Acid Isolation And Purification Market Report 2026
Automated Nucleic Acid Extraction Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.